Asterias stem cell therapy shows promise in spinal cord paralysis -U.S. study

NEW YORK, Sept 14 (Reuters) - An experimental stem cell

therapy developed by Asterias Biotherapeutics restored

some movement to patients paralyzed by recent spinal cord

injuries, according to interim...

Read more